nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0601	0.0717	CbGbCtD
Epinastine—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0565	0.0675	CbGbCtD
Epinastine—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0565	0.0675	CbGbCtD
Epinastine—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0511	0.061	CbGbCtD
Epinastine—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0428	0.0511	CbGbCtD
Epinastine—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0387	0.0462	CbGbCtD
Epinastine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.029	0.0347	CbGbCtD
Epinastine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.029	0.0346	CbGbCtD
Epinastine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0273	0.0326	CbGbCtD
Epinastine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0273	0.0326	CbGbCtD
Epinastine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0262	0.0313	CbGbCtD
Epinastine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0247	0.0295	CbGbCtD
Epinastine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0247	0.0295	CbGbCtD
Epinastine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0226	0.027	CbGbCtD
Epinastine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.022	0.0262	CbGbCtD
Epinastine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0213	0.0254	CbGbCtD
Epinastine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0207	0.0247	CbGbCtD
Epinastine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0199	0.0237	CbGbCtD
Epinastine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0199	0.0237	CbGbCtD
Epinastine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.019	0.0227	CbGbCtD
Epinastine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0187	0.0223	CbGbCtD
Epinastine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0187	0.0223	CbGbCtD
Epinastine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0185	0.022	CbGbCtD
Epinastine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0174	0.0207	CbGbCtD
Epinastine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0174	0.0207	CbGbCtD
Epinastine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0157	0.0187	CbGbCtD
Epinastine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0157	0.0187	CbGbCtD
Epinastine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0147	0.0176	CbGbCtD
Epinastine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0136	0.0162	CbGbCtD
Epinastine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0132	0.0157	CbGbCtD
Epinastine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0119	0.0142	CbGbCtD
Epinastine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0119	0.0142	CbGbCtD
Epinastine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0114	0.0136	CbGbCtD
Epinastine—Hyperaemia—Indinavir—acquired immunodeficiency syndrome	0.00832	0.0906	CcSEcCtD
Epinastine—Cough increased—Stavudine—acquired immunodeficiency syndrome	0.00339	0.037	CcSEcCtD
Epinastine—HTR7—nerve—acquired immunodeficiency syndrome	0.00261	0.0465	CbGeAlD
Epinastine—Cough increased—Efavirenz—acquired immunodeficiency syndrome	0.00259	0.0282	CcSEcCtD
Epinastine—Eye irritation—Saquinavir—acquired immunodeficiency syndrome	0.00237	0.0258	CcSEcCtD
Epinastine—Cough increased—Ritonavir—acquired immunodeficiency syndrome	0.00229	0.025	CcSEcCtD
Epinastine—HTR7—endothelium—acquired immunodeficiency syndrome	0.00222	0.0396	CbGeAlD
Epinastine—HTR7—blood plasma—acquired immunodeficiency syndrome	0.00197	0.0352	CbGeAlD
Epinastine—HRH2—skin of body—acquired immunodeficiency syndrome	0.00186	0.0333	CbGeAlD
Epinastine—Nasopharyngitis—Zidovudine—acquired immunodeficiency syndrome	0.00175	0.0191	CcSEcCtD
Epinastine—Sinusitis—Nelfinavir—acquired immunodeficiency syndrome	0.00164	0.0178	CcSEcCtD
Epinastine—Sinusitis—Stavudine—acquired immunodeficiency syndrome	0.00163	0.0178	CcSEcCtD
Epinastine—HTR2A—nerve—acquired immunodeficiency syndrome	0.00163	0.029	CbGeAlD
Epinastine—Rhinitis—Nelfinavir—acquired immunodeficiency syndrome	0.00157	0.0171	CcSEcCtD
Epinastine—Rhinitis—Stavudine—acquired immunodeficiency syndrome	0.00156	0.017	CcSEcCtD
Epinastine—Pharyngitis—Nelfinavir—acquired immunodeficiency syndrome	0.00155	0.0169	CcSEcCtD
Epinastine—Pharyngitis—Stavudine—acquired immunodeficiency syndrome	0.00155	0.0169	CcSEcCtD
Epinastine—Nasopharyngitis—Efavirenz—acquired immunodeficiency syndrome	0.00154	0.0168	CcSEcCtD
Epinastine—Pharyngitis—Abacavir—acquired immunodeficiency syndrome	0.00153	0.0166	CcSEcCtD
Epinastine—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.00151	0.0269	CbGeAlD
Epinastine—HRH2—digestive system—acquired immunodeficiency syndrome	0.00149	0.0266	CbGeAlD
Epinastine—Upper respiratory tract infection—Indinavir—acquired immunodeficiency syndrome	0.00146	0.016	CcSEcCtD
Epinastine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00145	0.0258	CbGeAlD
Epinastine—HRH2—blood—acquired immunodeficiency syndrome	0.00142	0.0253	CbGeAlD
Epinastine—Sinusitis—Zidovudine—acquired immunodeficiency syndrome	0.00142	0.0154	CcSEcCtD
Epinastine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00138	0.0247	CbGeAlD
Epinastine—Upper respiratory tract infection—Efavirenz—acquired immunodeficiency syndrome	0.00138	0.0151	CcSEcCtD
Epinastine—Rhinitis—Zidovudine—acquired immunodeficiency syndrome	0.00136	0.0148	CcSEcCtD
Epinastine—Pharyngitis—Zidovudine—acquired immunodeficiency syndrome	0.00135	0.0147	CcSEcCtD
Epinastine—Upper respiratory tract infection—Delavirdine—acquired immunodeficiency syndrome	0.00132	0.0144	CcSEcCtD
Epinastine—Sinusitis—Indinavir—acquired immunodeficiency syndrome	0.00132	0.0144	CcSEcCtD
Epinastine—Infection—Didanosine—acquired immunodeficiency syndrome	0.00127	0.0138	CcSEcCtD
Epinastine—Pharyngitis—Indinavir—acquired immunodeficiency syndrome	0.00125	0.0136	CcSEcCtD
Epinastine—Nasopharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.00125	0.0136	CcSEcCtD
Epinastine—Sinusitis—Efavirenz—acquired immunodeficiency syndrome	0.00125	0.0136	CcSEcCtD
Epinastine—HRH2—lung—acquired immunodeficiency syndrome	0.00125	0.0222	CbGeAlD
Epinastine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.00123	0.0219	CbGeAlD
Epinastine—Rhinitis—Efavirenz—acquired immunodeficiency syndrome	0.00119	0.013	CcSEcCtD
Epinastine—Sinusitis—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.013	CcSEcCtD
Epinastine—Cough—Stavudine—acquired immunodeficiency syndrome	0.00119	0.0129	CcSEcCtD
Epinastine—Upper respiratory tract infection—Saquinavir—acquired immunodeficiency syndrome	0.00118	0.0128	CcSEcCtD
Epinastine—Cough—Abacavir—acquired immunodeficiency syndrome	0.00117	0.0127	CcSEcCtD
Epinastine—HRH2—nervous system—acquired immunodeficiency syndrome	0.00115	0.0206	CbGeAlD
Epinastine—Rhinitis—Delavirdine—acquired immunodeficiency syndrome	0.00114	0.0125	CcSEcCtD
Epinastine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00114	0.0203	CbGeAlD
Epinastine—Pharyngitis—Delavirdine—acquired immunodeficiency syndrome	0.00113	0.0123	CcSEcCtD
Epinastine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00112	0.02	CbGeAlD
Epinastine—HRH2—central nervous system—acquired immunodeficiency syndrome	0.00111	0.0198	CbGeAlD
Epinastine—Sinusitis—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.012	CcSEcCtD
Epinastine—Infection—Abacavir—acquired immunodeficiency syndrome	0.00109	0.0118	CcSEcCtD
Epinastine—Sinusitis—Saquinavir—acquired immunodeficiency syndrome	0.00106	0.0116	CcSEcCtD
Epinastine—Rhinitis—Ritonavir—acquired immunodeficiency syndrome	0.00106	0.0115	CcSEcCtD
Epinastine—Pharyngitis—Ritonavir—acquired immunodeficiency syndrome	0.00105	0.0114	CcSEcCtD
Epinastine—Cough—Zidovudine—acquired immunodeficiency syndrome	0.00103	0.0112	CcSEcCtD
Epinastine—Rhinitis—Saquinavir—acquired immunodeficiency syndrome	0.00102	0.0111	CcSEcCtD
Epinastine—Sinusitis—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.011	CcSEcCtD
Epinastine—Pharyngitis—Saquinavir—acquired immunodeficiency syndrome	0.00101	0.011	CcSEcCtD
Epinastine—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000991	0.0108	CcSEcCtD
Epinastine—Rhinitis—Lamivudine—acquired immunodeficiency syndrome	0.000971	0.0106	CcSEcCtD
Epinastine—Pharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.000961	0.0105	CcSEcCtD
Epinastine—Cough—Indinavir—acquired immunodeficiency syndrome	0.000958	0.0104	CcSEcCtD
Epinastine—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000905	0.00986	CcSEcCtD
Epinastine—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000904	0.00984	CcSEcCtD
Epinastine—HRH2—brain—acquired immunodeficiency syndrome	0.000881	0.0157	CbGeAlD
Epinastine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000878	0.00956	CcSEcCtD
Epinastine—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000866	0.00944	CcSEcCtD
Epinastine—HRH2—lymph node—acquired immunodeficiency syndrome	0.000852	0.0152	CbGeAlD
Epinastine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000812	0.00885	CcSEcCtD
Epinastine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000806	0.0144	CbGeAlD
Epinastine—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000805	0.00877	CcSEcCtD
Epinastine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000801	0.00873	CcSEcCtD
Epinastine—Headache—Didanosine—acquired immunodeficiency syndrome	0.0008	0.00872	CcSEcCtD
Epinastine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000787	0.00857	CcSEcCtD
Epinastine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000784	0.00854	CcSEcCtD
Epinastine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000773	0.00842	CcSEcCtD
Epinastine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000771	0.0084	CcSEcCtD
Epinastine—HTR7—digestive system—acquired immunodeficiency syndrome	0.000758	0.0135	CbGeAlD
Epinastine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.00074	0.0132	CbGeAlD
Epinastine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000736	0.00801	CcSEcCtD
Epinastine—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000725	0.0129	CbGeAlD
Epinastine—HTR7—blood—acquired immunodeficiency syndrome	0.000722	0.0129	CbGeAlD
Epinastine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000719	0.00784	CcSEcCtD
Epinastine—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000716	0.0078	CcSEcCtD
Epinastine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000697	0.00759	CcSEcCtD
Epinastine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000697	0.0124	CbGeAlD
Epinastine—HTR7—spinal cord—acquired immunodeficiency syndrome	0.000696	0.0124	CbGeAlD
Epinastine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000695	0.00757	CcSEcCtD
Epinastine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000684	0.00745	CcSEcCtD
Epinastine—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000683	0.00744	CcSEcCtD
Epinastine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000682	0.00743	CcSEcCtD
Epinastine—HTR2A—retina—acquired immunodeficiency syndrome	0.000673	0.012	CbGeAlD
Epinastine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000634	0.00691	CcSEcCtD
Epinastine—HTR7—lung—acquired immunodeficiency syndrome	0.000633	0.0113	CbGeAlD
Epinastine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000604	0.00658	CcSEcCtD
Epinastine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000599	0.00653	CcSEcCtD
Epinastine—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000587	0.0105	CbGeAlD
Epinastine—HTR7—nervous system—acquired immunodeficiency syndrome	0.000586	0.0105	CbGeAlD
Epinastine—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.00058	0.0103	CbGeAlD
Epinastine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000573	0.00624	CcSEcCtD
Epinastine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000566	0.0101	CbGeAlD
Epinastine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000565	0.0101	CbGeAlD
Epinastine—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000564	0.0101	CbGeAlD
Epinastine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000561	0.00612	CcSEcCtD
Epinastine—CYP2B6—blood—acquired immunodeficiency syndrome	0.000552	0.00985	CbGeAlD
Epinastine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000544	0.00971	CbGeAlD
Epinastine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00053	0.00578	CcSEcCtD
Epinastine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00053	0.00577	CcSEcCtD
Epinastine—ADRA2A—blood—acquired immunodeficiency syndrome	0.00053	0.00945	CbGeAlD
Epinastine—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000512	0.00913	CbGeAlD
Epinastine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.00051	0.0091	CbGeAlD
Epinastine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00051	0.00556	CcSEcCtD
Epinastine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000508	0.00553	CcSEcCtD
Epinastine—HRH1—vagina—acquired immunodeficiency syndrome	0.0005	0.00892	CbGeAlD
Epinastine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000491	0.00876	CbGeAlD
Epinastine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000487	0.0053	CcSEcCtD
Epinastine—CYP2B6—lung—acquired immunodeficiency syndrome	0.000484	0.00863	CbGeAlD
Epinastine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000473	0.00843	CbGeAlD
Epinastine—HRH1—lung—acquired immunodeficiency syndrome	0.000473	0.00843	CbGeAlD
Epinastine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000469	0.00511	CcSEcCtD
Epinastine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000464	0.00828	CbGeAlD
Epinastine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000452	0.00492	CcSEcCtD
Epinastine—HTR2A—blood—acquired immunodeficiency syndrome	0.00045	0.00803	CbGeAlD
Epinastine—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000448	0.008	CbGeAlD
Epinastine—HTR7—brain—acquired immunodeficiency syndrome	0.000448	0.00799	CbGeAlD
Epinastine—ABCB1—retina—acquired immunodeficiency syndrome	0.000441	0.00787	CbGeAlD
Epinastine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000438	0.00781	CbGeAlD
Epinastine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000438	0.00781	CbGeAlD
Epinastine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000434	0.00774	CbGeAlD
Epinastine—ADRA1A—brain—acquired immunodeficiency syndrome	0.000432	0.00771	CbGeAlD
Epinastine—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000432	0.0077	CbGeAlD
Epinastine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000431	0.00469	CcSEcCtD
Epinastine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000431	0.00768	CbGeAlD
Epinastine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.00043	0.00767	CbGeAlD
Epinastine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000421	0.00752	CbGeAlD
Epinastine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000417	0.00745	CbGeAlD
Epinastine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000417	0.00744	CbGeAlD
Epinastine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000414	0.00738	CbGeAlD
Epinastine—CYP2D6—blood—acquired immunodeficiency syndrome	0.00041	0.00732	CbGeAlD
Epinastine—HTR2A—lung—acquired immunodeficiency syndrome	0.000395	0.00704	CbGeAlD
Epinastine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000366	0.00652	CbGeAlD
Epinastine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000352	0.00628	CbGeAlD
Epinastine—CYP2B6—brain—acquired immunodeficiency syndrome	0.000343	0.00611	CbGeAlD
Epinastine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000338	0.00604	CbGeAlD
Epinastine—HRH1—brain—acquired immunodeficiency syndrome	0.000335	0.00597	CbGeAlD
Epinastine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000333	0.00594	CbGeAlD
Epinastine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000329	0.00586	CbGeAlD
Epinastine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000326	0.00581	CbGeAlD
Epinastine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000323	0.00577	CbGeAlD
Epinastine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000321	0.00572	CbGeAlD
Epinastine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000318	0.00566	CbGeAlD
Epinastine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000314	0.00559	CbGeAlD
Epinastine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.00031	0.00553	CbGeAlD
Epinastine—ABCB1—blood—acquired immunodeficiency syndrome	0.000295	0.00526	CbGeAlD
Epinastine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000286	0.00509	CbGeAlD
Epinastine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000284	0.00507	CbGeAlD
Epinastine—HTR2A—brain—acquired immunodeficiency syndrome	0.000279	0.00498	CbGeAlD
Epinastine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000274	0.00488	CbGeAlD
Epinastine—ABCB1—lung—acquired immunodeficiency syndrome	0.000259	0.00461	CbGeAlD
Epinastine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000255	0.00454	CbGeAlD
Epinastine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.00024	0.00427	CbGeAlD
Epinastine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000231	0.00411	CbGeAlD
Epinastine—ABCB1—brain—acquired immunodeficiency syndrome	0.000183	0.00327	CbGeAlD
Epinastine—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000177	0.00316	CbGeAlD
Epinastine—Oxcarbazepine—ALB—acquired immunodeficiency syndrome	0.000104	0.513	CrCbGaD
Epinastine—Nortriptyline—ALB—acquired immunodeficiency syndrome	5.82e-05	0.288	CrCbGaD
Epinastine—Amitriptyline—ALB—acquired immunodeficiency syndrome	4.04e-05	0.2	CrCbGaD
Epinastine—ADRA2A—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	3.75e-05	0.00268	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.73e-05	0.00266	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.73e-05	0.00266	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	3.73e-05	0.00266	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	3.72e-05	0.00266	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.65e-05	0.00261	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.65e-05	0.00261	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	3.65e-05	0.00261	CbGpPWpGaD
Epinastine—ADRA2A—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	3.62e-05	0.00259	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.53e-05	0.00252	CbGpPWpGaD
Epinastine—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	3.51e-05	0.00251	CbGpPWpGaD
Epinastine—HTR7—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	3.39e-05	0.00242	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	3.39e-05	0.00242	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.37e-05	0.00241	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	3.37e-05	0.00241	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	3.37e-05	0.0024	CbGpPWpGaD
Epinastine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	3.33e-05	0.00238	CbGpPWpGaD
Epinastine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	3.32e-05	0.00237	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.32e-05	0.00237	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.32e-05	0.00237	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	3.3e-05	0.00236	CbGpPWpGaD
Epinastine—ADRA2A—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	3.27e-05	0.00233	CbGpPWpGaD
Epinastine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	3.26e-05	0.00233	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	3.17e-05	0.00226	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	3.17e-05	0.00226	CbGpPWpGaD
Epinastine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	3.17e-05	0.00226	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	3.16e-05	0.00226	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	3.16e-05	0.00226	CbGpPWpGaD
Epinastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	3.16e-05	0.00226	CbGpPWpGaD
Epinastine—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	3.12e-05	0.00223	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	3.1e-05	0.00222	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	3.1e-05	0.00222	CbGpPWpGaD
Epinastine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	3.1e-05	0.00221	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	3.1e-05	0.00221	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	3.09e-05	0.00221	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	3.07e-05	0.00219	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	3.03e-05	0.00217	CbGpPWpGaD
Epinastine—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	3.03e-05	0.00216	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	3.02e-05	0.00216	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	3.01e-05	0.00215	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.99e-05	0.00213	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.98e-05	0.00213	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	2.96e-05	0.00211	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—TAT—acquired immunodeficiency syndrome	2.93e-05	0.00209	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	2.88e-05	0.00206	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	2.88e-05	0.00206	CbGpPWpGaD
Epinastine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	2.88e-05	0.00206	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.86e-05	0.00204	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.86e-05	0.00204	CbGpPWpGaD
Epinastine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	2.85e-05	0.00204	CbGpPWpGaD
Epinastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	2.85e-05	0.00203	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	2.82e-05	0.00201	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	2.8e-05	0.002	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.8e-05	0.002	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.8e-05	0.002	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	2.8e-05	0.002	CbGpPWpGaD
Epinastine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	2.79e-05	0.00199	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.78e-05	0.00198	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	2.75e-05	0.00196	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—TAT—acquired immunodeficiency syndrome	2.75e-05	0.00196	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	2.74e-05	0.00196	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.74e-05	0.00195	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.7e-05	0.00193	CbGpPWpGaD
Epinastine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	2.6e-05	0.00185	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.59e-05	0.00185	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	2.55e-05	0.00182	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.54e-05	0.00181	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.54e-05	0.00181	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.52e-05	0.0018	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.5e-05	0.00179	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—AGPS—acquired immunodeficiency syndrome	2.49e-05	0.00178	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.49e-05	0.00177	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—IFNA1—acquired immunodeficiency syndrome	2.47e-05	0.00176	CbGpPWpGaD
Epinastine—ADRA2A—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	2.44e-05	0.00174	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.41e-05	0.00172	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.41e-05	0.00172	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.36e-05	0.00169	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.34e-05	0.00167	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.31e-05	0.00165	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.27e-05	0.00162	CbGpPWpGaD
Epinastine—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	2.27e-05	0.00162	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	2.19e-05	0.00157	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.17e-05	0.00155	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.17e-05	0.00155	CbGpPWpGaD
Epinastine—HTR7—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.16e-05	0.00154	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.13e-05	0.00152	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	2.13e-05	0.00152	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.1e-05	0.0015	CbGpPWpGaD
Epinastine—HTR2A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	2.1e-05	0.0015	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.08e-05	0.00149	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	2.03e-05	0.00145	CbGpPWpGaD
Epinastine—ADRA2A—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	1.98e-05	0.00141	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	1.98e-05	0.00141	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.96e-05	0.0014	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.96e-05	0.0014	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.93e-05	0.00138	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—CSF2—acquired immunodeficiency syndrome	1.93e-05	0.00138	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.92e-05	0.00137	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.91e-05	0.00137	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.91e-05	0.00136	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	1.91e-05	0.00136	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.91e-05	0.00136	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.9e-05	0.00136	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.9e-05	0.00136	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.87e-05	0.00134	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.87e-05	0.00133	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.83e-05	0.00131	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.83e-05	0.00131	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.83e-05	0.0013	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.83e-05	0.0013	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.79e-05	0.00128	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.79e-05	0.00128	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.79e-05	0.00128	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.79e-05	0.00128	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.79e-05	0.00128	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.79e-05	0.00128	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.77e-05	0.00126	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.75e-05	0.00125	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.75e-05	0.00125	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.74e-05	0.00124	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.74e-05	0.00124	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.73e-05	0.00124	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.73e-05	0.00124	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.73e-05	0.00123	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.72e-05	0.00123	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.69e-05	0.00121	CbGpPWpGaD
Epinastine—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	1.69e-05	0.00121	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.66e-05	0.00119	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.66e-05	0.00119	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.66e-05	0.00118	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.65e-05	0.00118	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.63e-05	0.00116	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.63e-05	0.00116	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.63e-05	0.00116	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.63e-05	0.00116	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.62e-05	0.00116	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.62e-05	0.00116	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.62e-05	0.00116	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.62e-05	0.00116	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.6e-05	0.00114	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.59e-05	0.00114	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.59e-05	0.00114	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.57e-05	0.00112	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.51e-05	0.00107	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.5e-05	0.00107	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.5e-05	0.00107	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.49e-05	0.00106	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.48e-05	0.00106	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.48e-05	0.00106	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.47e-05	0.00105	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.45e-05	0.00103	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.36e-05	0.000973	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.36e-05	0.000971	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.34e-05	0.000959	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.34e-05	0.000959	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.34e-05	0.000957	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.33e-05	0.000953	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.31e-05	0.000939	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.31e-05	0.000938	CbGpPWpGaD
Epinastine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.31e-05	0.000934	CbGpPWpGaD
Epinastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.31e-05	0.000932	CbGpPWpGaD
Epinastine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.28e-05	0.000915	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	1.26e-05	0.000899	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.25e-05	0.000891	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.24e-05	0.000885	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.24e-05	0.000884	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.24e-05	0.000882	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.23e-05	0.000877	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.23e-05	0.000875	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.22e-05	0.000872	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.22e-05	0.000871	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.22e-05	0.000869	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.21e-05	0.000865	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.2e-05	0.000858	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.19e-05	0.000852	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.14e-05	0.000815	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.13e-05	0.000807	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.13e-05	0.000805	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.13e-05	0.000804	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.13e-05	0.000803	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.12e-05	0.000801	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.12e-05	0.000798	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.12e-05	0.000796	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.11e-05	0.000794	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.11e-05	0.000792	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.11e-05	0.000791	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.11e-05	0.00079	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.09e-05	0.00078	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.06e-05	0.000757	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.03e-05	0.000735	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.03e-05	0.000734	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.02e-05	0.00073	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.02e-05	0.000729	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.02e-05	0.000728	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.01e-05	0.000724	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.01e-05	0.000719	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1e-05	0.000715	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.61e-06	0.000686	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.61e-06	0.000686	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.59e-06	0.000685	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.59e-06	0.000685	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.41e-06	0.000672	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.41e-06	0.000672	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.3e-06	0.000664	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.75e-06	0.000624	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.75e-06	0.000624	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.76e-06	0.000554	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.72e-06	0.000551	CbGpPWpGaD
Epinastine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	7.54e-06	0.000538	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.31e-06	0.000522	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.3e-06	0.000521	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.2e-06	0.000514	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.19e-06	0.000513	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.16e-06	0.000511	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.1e-06	0.000507	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.08e-06	0.000505	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.05e-06	0.000504	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.95e-06	0.000496	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.65e-06	0.000475	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.59e-06	0.00047	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.57e-06	0.000469	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.55e-06	0.000468	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.46e-06	0.000461	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.45e-06	0.000461	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.44e-06	0.00046	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.43e-06	0.000459	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.31e-06	0.00045	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.99e-06	0.000428	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.95e-06	0.000424	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.92e-06	0.000422	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.86e-06	0.000419	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	5.11e-06	0.000365	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—ALB—acquired immunodeficiency syndrome	4.79e-06	0.000342	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.56e-06	0.000326	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.81e-06	0.000272	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.8e-06	0.000271	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.79e-06	0.00027	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.78e-06	0.00027	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.73e-06	0.000266	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.71e-06	0.000265	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	3.53e-06	0.000252	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.5e-06	0.00025	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.46e-06	0.000247	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.45e-06	0.000246	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	3.33e-06	0.000238	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.24e-06	0.00016	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.23e-06	0.000159	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.19e-06	0.000156	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.18e-06	0.000155	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.04e-06	0.000145	CbGpPWpGaD
